Recent Finacing
Recent Raise
Exonate is an early-stage biotech developing selective SRPK1-inhibiting small molecules that modulate VEGF splicing to treat angiogenic diseases (wet AMD, cancer), diabetic complications, nerve/kidney protection and analgesia.
